Global Trade Alert
Global Trade Alert

Back to state act

Norway: Introduction of export notification requirement on Tixagevimab–cilgavimab, Sotrovimab, and Casirivimab-imdevimab

Description

On 14 October 2022, the Norwegian Medicines Agency introduced an export notification requirement on the following drugs: Tixagevimab–cilgavimab, Sotrovimab, and Casirivimab-imdevimab. According to the...

Sign in to see full description

Intervention Details

Intervention Type

Export licensing requirement

MAST Chapter

P: Export-related measures (incl. subsidies)

Implementation date

14 Oct 2022

Revocation date

01 Jul 2023

Implementation level

National

Affected flow

Outward

Announced as temporary

Yes

Eligible firms

all

Affected Trading Partners

Graph

Table

Affected Sectors

Sign in to access 1 sectors

Affected Products

Sign in to access 1 products

Threads

See all

This intervention is not part of any Thread yet.